SMC®人IL-17F高灵敏度试剂盒，1KIT，03-0164-00，密理博

General description

SMC^®人IL-17F高灵敏度免疫分析试剂盒包含进行分析所需的所有试剂。该测定采用以标准孔板形式配置的标准免疫测定工作流程。

测定方案与现有的夹心ELISA方法相似，但有两个主要区别：
1）洗脱缓冲液破坏夹心结构，分离标记的检测抗体以进行定量。
2）Erenna 和SMCxPRO^® 免疫测定系统使用单分子计数（SMC^®）技术对分析物进行检测。

Application

Inflammatory Disease / Immune Response / Autoimmune Disease

Features and Benefits

• Detect the Undectable: Detects IL-17F at concentrations as low as 200 fg/mL, enabling precise quantification of low-abundance cytokines in human plasma and serum.
• Wide Dynamic Range: Standard curve spans 100-100,000 fg/mL, supporting both basal and elevated IL-17F levels in diverse sample types.
• Advance Th17 Pathway Research: IL-17F is a critical cytokine in autoimmune and inflammatory diseases such as asthma, psoriasis, and IBD. This assay supports mechanistic studies and therapeutic development.
• Enable Early Biomarker Discovery: Detect subclinical cytokine shifts with high sensitivity, ideal for identifying early disease markers and monitoring immune responses.

Packaging

96 well assay

Analysis Note

• Sensitivity: LLOQ 200 fg/mL* (SMCxPRO^® Instrument)
• Standard Curve Range: 100-100,000 fg/mL
• Intra-assay CV: <15%
• Inter-assay CV: <20%
• Linearity: Serum: 99% Plasma: 101%
• Recovery: Serum: 94% Plasma: 105%

Other Notes

Although IL-17F was detectable in non-human primate samples, the assay has not been verified for these species.

Legal Information

FEMTOQUEST is a trademark of Merck KGaA, Darmstadt, Germany
SMC is a registered trademark of Singulex
SMCxPRO is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

我们的产品仅用于研究目的，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用对人类或动物。